Cadisegliatin with Insulin and Insulin Pump for Type 1 Diabetes
Treatments studied
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new medication called cadisegliatin added to insulin therapy in people with type 1 diabetes who use an insulin pump with automated features. The goal is to see if this combination helps keep blood sugar in a healthier range more of the time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have type 1 diabetes (not type 2 or other diabetes types)
- You've been using a hybrid closed-loop insulin pump (one with automated features) for at least 3 months and can keep using the same pump model during the study
- Your blood sugar control is not yet at goal (less than 70% of the time in healthy range) even with your current pump
- You are willing to wear a study-provided continuous glucose monitor (CGM—a sensor that reads blood sugar)
- You can safely do a 30-minute exercise test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This study tests whether adding a weekly injection of tirzepatide (a drug that helps with blood sugar and weight) can improve glucose control in adults with type 1 diabetes who already use an automated insulin pump. It may help you if your blood sugar is not at target despite using a pump.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests an upgraded automated insulin pump system that uses artificial intelligence to better predict and prevent blood sugar swings. If you have Type 1 Diabetes and already use an automated insulin pump, this trial may help you achieve better blood sugar control.
This trial tests if adding tirzepatide (a once-weekly injection) to an automated insulin pump system (Control-IQ) helps adults with type 1 diabetes better manage their blood sugar. It requires using the Tandem Control-IQ pump and counting carbohydrates.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.